Improved Potency of Hyperactive and Actin-resistant Human DNase I Variants for Treatment of Cystic Fibrosis and Systemic Lupus Erythematosus
Open Access
- 1 July 1998
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (29) , 18374-18381
- https://doi.org/10.1074/jbc.273.29.18374
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Hyperactivity of Human DNase I VariantsPublished by Elsevier ,1998
- Engineering Hyperactive Variants of Human Deoxyribonuclease I by Altering Its Functional MechanismBiochemistry, 1997
- Identification, Localization, and Expression of Two Novel Human Genes Similar to Deoxyribonuclease IGenomics, 1997
- Cloning and Characterization of a Novel Human DNaseBiochemical and Biophysical Research Communications, 1997
- Management of Pulmonary Disease in Patients with Cystic FibrosisNew England Journal of Medicine, 1996
- Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.Genome Research, 1995
- Nucleosomal anatomy – where are the histones?BioEssays, 1995
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- X-ray structure of the DNase I-d(GGTATACC)2 complex at 2·3Å resolutionJournal of Molecular Biology, 1992
- Atomic structure of the actin: DNase I complexNature, 1990